Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 4/1/2026Salubris Unveils Long-Acting Blood Pressure siRNA Data at ACC 2026
  • 4/1/2026Alphamab and CSPC Win Phase III Breast Cancer Success for KN026 Neo-He...
  • 4/1/2026Bayer Secures Nearly Five-Year China Patent Extension for Kerendia
  • 4/1/2026China CDE Opens Public Consultation on 105th Batch of Chemical Generic...
  • 4/1/2026China Tightens Health Insurance Fund Oversight With New Anti-Fraud Rul...
  • 4/1/2026Fosun Pharma Wins China Trial Nod for Teva-Partnered FXB0871
  • 4/1/2026Pierre Fabre Deepens China Commitment as Pharma and Dermo-Cosmetics Gr...
  • 4/1/2026Erasca Secures Worldwide Rights to Joyo's Pan-RAS Molecular Glue with ...
  • 4/1/2026Abbisko Wins EMA Orphan Drug Designation for Irpagratinib in Liver Can...
  • 3/31/2026IMPACT Therapeutics Renews Hong Kong IPO Push With Updated Filing
  • 3/31/2026Syneron Bio Closes Major Series B to Advance AI-Driven Macrocyclic Pep...
  • 3/31/2026Biocytogen Licenses RenNano® Antibody Discovery Platform to Taisho Ph...
  • 3/31/2026NHSA Deepens Dialogue With MNC Pharma on Innovation Drug Value and Rea...
  • 3/31/2026NMPA Moves to Strengthen China's Conditional Drug Approval Framework
  • 3/31/2026CK Life Sciences Moves to Fast-Track China Cancer Vaccine Development ...
  • 3/31/2026Huahui Launches World's First Approved Hepatitis D Antibody Drug in Ch...
  • 3/31/2026Connect Biopharma Reports Promising Late-Stage China Results for Eczem...
  • 3/31/2026Braveheart Bio Posts Promising Mid-Stage China Data for HCM Drug Licen...
  • 3/31/2026China's Innovative Drug Out-Licensing Nears Half of 2025 Total in Firs...
  • 3/31/2026Santen Accelerates China Strategy by Moving Earlier Into Global Ophtha...
  • 3/31/2026Innovent Publishes Strong Phase II Mazdutide 9 mg Obesity Data as Chin...
  • 3/31/2026Simcere Highlights Late-Breaking Phase III Success for Rademikibart in...
  • 3/30/2026NMPA Releases 103rd Batch of Generic Drug Reference Formulations Catal...
  • 3/30/2026Dizal Reports Strong First-Line ELCC 2026 Data for ZEGFROVY in Uncommo...
  • 3/30/2026Enhertu Wins First Global Approval in Neoadjuvant HER2-Positive Early ...
  • 3/30/2026BioRay and UCB Win Dual China Dermatology Approvals for Bimzelx
  • 3/30/2026China Approves Claruvis's Retoxin, Marking New Milestone in Recombinan...
  • 3/30/2026Almirall Partners Shanghai Huaota in $340 Million Dermatology Antibody...
  • 3/30/2026AZ/Amgen's Tezspire Wins China Approval for Asthma and CRSwNP
  • 3/30/2026GSK's Exdensur Wins China Approval for Severe Eosinophilic Asthma
  • Page:1/61 Total number of articles:1824: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group